Otsuka Holdings Co., Ltd. Logo

Otsuka Holdings Co., Ltd.

Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.

4578 | T

Overview

Corporate Details

ISIN(s):
JP3188220002
LEI:
Country:
Japan
Address:
千代田区神田司町2−9
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Otsuka Holdings Co., Ltd. is a global healthcare group operating under the corporate philosophy of 'Otsuka-people creating new products for better health worldwide.' The company's operations are centered around two core segments: the Pharmaceutical Business and the Nutraceutical Business. The Pharmaceutical division focuses on the research, development, manufacturing, and sale of innovative products for the diagnosis and treatment of diseases, with a strong presence in areas such as central nervous system disorders, oncology, and cardiovascular diseases. The Nutraceutical division provides products that support daily health maintenance and improvement, including functional foods and beverages like POCARI SWEAT and SOYJOY, as well as 'Cosmedics' (cosmetics + medicine). The group is committed to a holistic approach to health, creating highly original products to contribute to the well-being of people globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-31 09:22
Report Publication Announcement
確認書
Japanese 8.3 KB
2025-07-31 09:21
Interim Report
半期報告書-第18期(2025/01/01-2025/12/31)
Japanese 340.0 KB
2025-05-22 03:58
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 101.5 KB
2025-05-12 06:10
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.1 KB
2025-05-08 09:07
Prospectus
発行登録書(株券、社債券等)
Japanese 26.0 KB
2025-05-07 09:48
Major Shareholding Notification
臨時報告書
Japanese 21.0 KB
2025-05-02 09:29
M&A Activity
訂正臨時報告書
Japanese 29.3 KB
2025-04-14 09:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.6 KB
2025-04-01 09:00
Post-Annual General Meeting Information
臨時報告書
Japanese 25.5 KB
2025-04-01 09:00
Share Issue/Capital Change
臨時報告書
Japanese 41.6 KB
2025-03-31 04:06
Registration Form
確認書
Japanese 8.3 KB
2025-03-31 04:05
Governance Information
内部統制報告書-第17期(2024/01/01-2024/12/31)
Japanese 23.9 KB
2025-03-31 04:04
Annual Report
有価証券報告書-第17期(2024/01/01-2024/12/31)
Japanese 3.3 MB
2025-03-21 08:16
Major Shareholding Notification
臨時報告書
Japanese 20.7 KB
2025-03-14 08:09
M&A Activity
訂正臨時報告書
Japanese 26.2 KB

Automate Your Workflow. Get a real-time feed of all Otsuka Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Otsuka Holdings Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Otsuka Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AIM ImmunoTech Inc. Logo
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America
AIM
AKANDA CORP. Logo
Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.
United States of America
AKAN
Akari Therapeutics Plc Logo
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America
AKBA
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
Alaunos Therapeutics, Inc. Logo
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America
TCRT
Aldeyra Therapeutics, Inc. Logo
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America
ALDX
Alector, Inc. Logo
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America
ALEC
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark
ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.